StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Mayne Pharma Group Limited
ASX:MYX.AX
Sector
Location
Market Cap
USD 283.36 M
Share Price
USD 3.43
Avg Daily Volume
840,535
Change (1 day)
0.80%
Change (1 year)
21.73%
Change (YTD)
11.35%
Mayne Pharma Group Limited EBITDA for the year ending June 30, 2024: USD -77.96 M
Mayne Pharma Group Limited EBITDA is USD -77.96 M for the year ending June 30, 2024, a -39.55% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Mayne Pharma Group Limited EBITDA for the year ending June 30, 2023 was USD -128.98 M, a 136.92% change year over year.
-
Mayne Pharma Group Limited EBITDA for the year ending June 30, 2022 was USD -54.44 M, a -60.19% change year over year.
-
Mayne Pharma Group Limited EBITDA for the year ending June 30, 2021 was USD -136.76 M, a 482.16% change year over year.
-
Mayne Pharma Group Limited EBITDA for the year ending June 30, 2020 was USD -23.49 M, a -86.13% change year over year.
Competitors
Eli Lilly and Company
USD 790.65
LLY
+3.73
0.47%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
GSK plc
USD 19.73
GSK.L
+0.37
1.92%
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
Regeneron Pharmaceuticals, Inc.
USD 559.76
REGN
+7.18
1.30%
Cencora, Inc.
USD 297.32
COR
-2.84
-0.95%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.07
0.91%
Takeda Pharmaceutical Company Limited
USD 29.72
4502.T
+0.09
0.30%
Haleon plc
USD 5.05
HLN.L
+0.06
1.21%
Daiichi Sankyo Company, Limited
USD 22.09
4568.T
+0.15
0.68%
Ucb S.A.
USD 201.93
UCB.BR
+2.35
1.18%
BeOne Medicines Ltd.
USD 253.39
ONC
-2.30
-0.90%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
Eli Lilly and Company
USD 790.65
LLY
+3.73
0.47%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
GSK plc
USD 19.73
GSK.L
+0.37
1.92%
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
Regeneron Pharmaceuticals, Inc.
USD 559.76
REGN
+7.18
1.30%
Cencora, Inc.
USD 297.32
COR
-2.84
-0.95%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.07
0.91%
Takeda Pharmaceutical Company Limited
USD 29.72
4502.T
+0.09
0.30%
Haleon plc
USD 5.05
HLN.L
+0.06
1.21%
Daiichi Sankyo Company, Limited
USD 22.09
4568.T
+0.15
0.68%
Ucb S.A.
USD 201.93
UCB.BR
+2.35
1.18%
BeOne Medicines Ltd.
USD 253.39
ONC
-2.30
-0.90%